Health care resource utilization (HCRU) with asciminib and bosutinib among patients with chronic myeloid leukemia in chronic phase (CML-CP) previously treated with ≥2 tyrosine kinase inhibitors (TKIs): Results from the multicenter, open-label phase 3 ASCEMBL trial Meeting Abstract
| Authors: | Smith, B. D.; Cortes, J. E.; Rea, D.; Mauro, M. J.; Patwardhan, P.; Maegawa, R.; Zacker, C.; Corbin, R.; Keeping, S.; Sasaki, K. |
| Abstract Title: | Health care resource utilization (HCRU) with asciminib and bosutinib among patients with chronic myeloid leukemia in chronic phase (CML-CP) previously treated with ≥2 tyrosine kinase inhibitors (TKIs): Results from the multicenter, open-label phase 3 ASCEMBL trial |
| Meeting Title: | 9th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | cml; chronic myeloid leukemia; tyrosine kinase inhibitor; bosutinib; asciminib; health care resource use |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 21 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Sep 8-11 |
| Meeting Location: | Virtual event |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-09-01 |
| Start Page: | S334 |
| Language: | English |
| ACCESSION: | WOS:000691910500219 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(21)01781-x |
| Notes: | Meeting Abstract: CML-353 -- Source: Wos |
